Kroger Health and PTS Diagnostics Announce CardioChek Plus Partnership

News Provided by Kroger Health 

Kroger Health and PTS Diagnostics Partner to Help Americans Better Prevent, Diagnose and Treat Diabetes and Heart Disease

CardioChek® Plus analyzer to be rolled out in more than 2,000 Kroger Health clinics and pharmacies across the country

INDIANAPOLIS (Jan. 29, 2019) – PTS Diagnostics, a U.S.-based manufacturer of point-of-care testing devices and Kroger Health, The Kroger Co.’s nationwide arm of health and wellness facilities, services and programs, announced today the full rollout of CardioChek Plus analyzers for point-of-care blood testing to help identify individuals at-risk of heart attack, stroke, and diabetes.

CardioChek Plus analyzers provide accurate, on-site results in as little as 90 seconds using the same technology as clinical laboratories. Its speed and portability combined with the reach and influence of Kroger Health pharmacies and clinics will increase the number of potential patients who are able to receive preventative health screenings and begin clinical protocols.

“With nearly one-third of Americans suffering from diabetes, prediabetes, or high-cholesterol, the time for more innovative and turnkey solutions is now,” said Colleen Lindholz, President, Kroger Health. “One of the best ways to combat these issues is to ‘know your numbers’. And that’s why easy, economical and efficient testing methods are so important. When you know if you’re at-risk, you can take the actions necessary – whether that is with your diet, exercise or medication – to begin living a healthier life.” 

The CardioChek Plus system accurately tests lipid profile and glucose simultaneously with one fingerstick, eliminating the need for additional testing or machinery, and enabling a more seamless process for the customer. It is one of the fastest, most cost-efficient, and user-friendly analyzers in the world. The system measures total cholesterol, HDL cholesterol, triglycerides and glucose, and provides real-time readings and ratios that are immediately documented by trained associates onsite. Because of its handheld, portable design, the CardioCheck Plus analyzers are easy to transport, store and operate. 

Implementing the switch to The CardioChek Plus in all Kroger Health locations is another meaningful move towards eliminating preventable disease through early identification, targeting disease progression. Additionally, the speed and portability of The CardioChek Plus combined with the reach and influence of Kroger Health pharmacies and clinics increases the number of patients able to receive preventive screenings and begin clinical protocols.

“Our partnership with Kroger Health is an important step towards improving the overall state of population health,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “Nearly 90 percent of Americans live within five miles of a Kroger Health pharmacy or clinic and theseindividuals can now be quickly monitored for cardiometabolic conditions.”

Kroger Health includes more than 22,000 healthcare associates across over 2,100 pharmacies and clinics. Their trained professionals provide services, treatment and coaching in multiple areas, from nutrition counseling and weight loss programs, to diabetes prevention and immunization services. The CardioChek Plus rollout coincides with Kroger Health’s broader health and wellness initiatives, including the “Wellness Your Way” campaign, designed to provide personalized solutions for healthcare to the more than 60 million Americans who visit the Kroger family of companies – including Kroger, Ralph’s, Fry’s, and Fred Meyer – each year.

The CardioChek Plus is FDA – cleared, CLIA – waived and meets National Cholesterol Education Program (NCEP) guidelines for accuracy and precision. The final rollout of analyzers will be complete by February 2019.

About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 140 countries around the globe. For more information, visit ptsdiagnostics.com.

About Whitmire Medical:
Established in 1986, Whitmire Medical specializes in point of care diagnostic solutions for pharmacy and IDN applications. Utilizing a consultative approach, we partner with users to deliver best-in-class products and services tailored to their needs with a focus on optimizing clinical, operational and financial outcomes. Beyond exceptional pricing and traditional distribution functions, Whitmire offers personalized logistic and implementation support, training, and troubleshooting assistance by AACC educated POC specialists. For more information, visit www.whitmiremedical.com.

About The Kroger Co.
At The Kroger Co. (NYSE: KR), we are dedicated to our Purpose: to Feed the Human Spirit™. We are nearly half a million associates who serve over nine million customers daily through a seamless digital shopping experience and 2,800 retail food stores under a variety of banner names, serving America through food inspiration and uplift, and creating #ZeroHungerZeroWaste communities by 2025. To learn more about us, visit our newsroom and investor relations site.

Press Contacts:
The Kroger Co.
Customer Relations
513-762-4000, info@thekrogerco.com

PTS Diagnostics
Ryan Simpson, Senior Marketing Associate
317-870-5610 – rsimpson@ptsdiagnostics.com

PTS Diagnostics Promotes Two, Reorganizes Sales Team

PTS Diagnostics Promotes Two, Reorganizes Sales Team

Realignment of domestic sales force supports outcome-based healthcare system

INDIANAPOLIS (Feb. 19, 2019) – PTS Diagnostics, a U.S.-based manufacturer of point-of-care biometric testing devices, today announced that they have established and filled new domestic sales positions.

We are proud to celebrate the following additions to the PTS Diagnostics family:

Ken Kimker and Jennifer Leding are assuming the roles of Directors, Distribution.

Kimker joined PTS Diagnostics in 2015 and Leding in 2016 as Area Sales Managers. Both have distinguished themselves in their abilities to demonstrate the value of point-of-care solutions to ACOs and healthcare systems. In their new roles, they’ll work closely with our national distribution partners and assist with the launch of PreVantage, our new wellness brand.

PTS Diagnostics has also added the positions of Senior Managers, PreVantage Solutions. In addition to tenured members of our U.S. sales organization who are taking on these titles, we’re excited to welcome Jason Edwards, Michael Kraus, and Jeff Robertson.

These individuals come to us with extensive knowledge of healthcare reimbursement and are experienced solution sellers. We’re excited to utilize these new positions in order to further grow the PreVantage brand in numerous verticals.

“The continued evolution of our sales force aligns with our organizational philosophy of expanding upon the markets we serve in order to reach as many individuals afflicted with cardiometabolic conditions as possible,” said Cliffe Allen, Vice President, U.S. Sales, at PTS Diagnostics. “These new roles are essential to impacting those most affected by shifts in healthcare such as MIPS and MACRA. We’re excited to watch these individuals grow and thrive.”

This realignment precedes the move to a new global headquarters in Whitestown, Ind. which is anticipated to open in spring of 2019. 

About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-ofcare medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 140 countries around the globe. For more information, visit ptsdiagnostics.com.

Press Contact:
Ryan Simpson, Senior Marketing Associate
317-870-5610
rsimpson@ptsdiagnostics.com

PTS Diagnostics Announces Full Program Availability for PreVantage

PTS Diagnostics Announces Full Program Availability for PreVantage

Subscription-Based Solutions Assist Healthcare Industry With Maximizing Reimbursement

INDIANAPOLIS – PTS Diagnostics, a U.S.-based manufacturer of point-of-care testing devices, announced today the full availability of the PreVantage population health program which includes product solutions and strategic partnerships. 

“We’re excited to evolve from a product-based organization into a turnkey solutions provider,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “The PreVantage suite of solutions will help PTS Diagnostics deliver unprecedented value in regards to assisting providers with maximizing healthcare reimbursement in a value-based model while improving both patient and provider satisfaction, and ultimately achieving measurable improvements in overall population health.”

This new brand is the culmination of extensive evidence-based research into the world of value-based incentivization and was developed to address the complex needs of multiple markets served by PTS Diagnostics.

“PTS Diagnostics is uniquely positioned to deliver this program as our product solutions generate the data required to help systems achieve the mandates of the Quadruple Aim, while helping providers maximize reimbursement under MIPS Advanced Alternative Payment Models,” said Steve Riendeau, Chief Commercial Officer of PTS Diagnostics. “By combining our products with leading software solutions under the PreVantage umbrella, we are also helping providers accelerate initiatives such as remote patient monitoring and chronic disease management program implementation.” 

PreVantage is composed of the following elements:

PreVantage Product Solutions are customized into two separate medical device convenience kits.

The A1CNow®+ product solution contains the 10-count A1CNow+ professional system with lancets, a removable pouch for ancillary components, and a robust outer case for greater mobility, protection, and storage.
The CardioChek® Plus product solution contains a professional CardioChek Plus analyzer, PTS Panels® Lipid + eGLU Smart Bundle 2-pack, lancets, PTS Collect 40 μL capillary tubes, PTS Panels Multi-Chemistry Controls, a removable pouch for ancillary components, and a robust outer case for greater mobility, protection, and storage.

These solutions come with an extended service agreement and warranty, as well as a lifetime guarantee on the outer case itself. PreVantage Product Solutions have the potential for expansion and customization as we explore new partnerships within the healthcare industry which support the PreVantage mission.

PreVantage ConnectedCare, powered by Rimidi, is a population health chronic disease management solution, created by medical professionals, for medical professionals and patients. It unlocks the meaning in patient data, enabling personalized, focused, point-of-care solutions that can help improve outcomes, which is critical to provider reimbursement maximization. It works seamlessly into the physician or care team’s workflow and integrates directly with providers’ Electronic Health Records (EHRs), leveraging emerging industry standards like SMART on FHIR.

PreVantage ConnectedQC, powered by eTrueNorth, is a point-of-care focused quality control management solution which assists users of PTS Diagnostics product solutions in managing their QC requirements in a manner consistent with current regulatory standards. PreVantage customers are also granted preferred access to eTrueNorth’s eQC suite of policy and procedure and national and state regulatory requirement management programs.

PTS Connect® ScreenPro, powered by StatBridge, assists healthcare systems with managing population-based and employer health screening events while connecting PTS Diagnostics’ systems to data capture solutions.

PTS Connect® ProLink, powered by mHealthAlert, wirelessly receives and securely stores biometric data from various diagnostics devices and delivers a personalized wellness report.

PreVantage will continue to expand nationally as healthcare shifts from a fee-for-service model to value-based incentivization. The brand will also mature globally as PTS Diagnostics assists with meeting unique healthcare needs abroad.

Interested parties are encouraged to visit ptsdiagnostics.com/prevantage, reach out to PTS Diagnostics via phone at 877-870-5610, or email at customerservice@ptsdiagnostics.com for more information.

About PTS Diagnostics Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 130 countries around the globe. For more information, visit ptsdiagnostics.com.

About PreVantage
PreVantage is a network of products, strategies, and partnerships aimed at helping healthcare organizations meet rapidly changing industry and consumer demands. By connecting innovations in technology, healthcare delivery, and payment models, PreVantage helps healthcare providers improve efficiency, lower costs, and increase reimbursements while delivering better health outcomes. More information is available at ptsdiagnostics.com/PreVantage.

Press Contact:
Ryan Simpson, Senior Marketing Associate
317-870-5610 – rsimpson@ptsdiagnostics.com

PTS Diagnostics’ Global Headquarters Opening May 20 in Whitestown, Indiana

PTS Diagnostics’ Global Headquarters Opening May 20 in Whitestown, Indiana

State-of-the-art facility to serve as global manufacturing hub

INDIANAPOLIS (May 15, 2019) – PTS Diagnostics, a U.S.–based manufacturer of point-of-care biometric testing devices, today announced that their new global headquarters is officially opening to all Indianapolis-area employees on Monday, May 20.

Located at 4600 Anson Boulevard, the 135,000 square foot facility will feature expanded manufacturing and office space, as well as amenities such as a walking trail, fitness center, zen garden, rec room, and more. The facility has recently led to material hiring in key departments such as research and development, operations, and manufacturing; a trend that PTS Diagnostics expects to continue for the foreseeable future.

The grand opening comes nearly a year to the day after a private groundbreaking ceremony was held with executives, architects, builders, and representatives from PTS Diagnostics’ parent company, Sinocare, Inc.

“Our growth rate has been significantly above the industry average for the past several years. This facility greatly expands our capacity, while ensuring that Indiana will remain our long-term home,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “Ultimately, it’s our vision to be recognized as the leading global customer-driven partner for providing innovative point-of-care solutions for preventative healthcare and disease management. This headquarters provides us with the resources to make this goal a reality.”

PTS Diagnostics employs more than 240 full-time employees domestically and internationally, with the majority of those employees residing at our new flagship location in Whitestown. PTS Diagnostics also has a Sunnyvale, California location which was acquired in 2013. 

The company is currently hiring in the fields of engineering, regulatory and compliance, sales, manufacturing and production, research and development, and marketing. Interested applicants are encouraged to monitor the PTS Diagnostics career center at ptsdiagnostics.com/career-center.

“We are pleased that PTS Diagnostics has chosen to bring their global headquarters to Whitestown,” said Molly Whitehead, Executive Director of the Boone County Economic Development Corporation. “We are confident that a thriving company like PTS Diagnostics will find Boone County to be a good fit for their operations.”

A ribbon-cutting celebration is scheduled for Saturday, June 22, employees, Whitestown business leaders, and members of the media are welcome to attend. More information will be available at a later date.

The old facility, located at 7736 Zionsville, Road, will remain open for disaster recovery and manufacturing needs. 

About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 140 countries around the globe. For more information, visit ptsdiagnostics.com.

Press Contact:
Ryan Simpson, Senior Marketing Associate
317-870-5610
rsimpson@ptsdiagnostics.com